Deferasirox-induced serious adverse reaction in a pediatric patient: pharmacokinetic and pharmacogenetic analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deferasirox-induced serious adverse reaction in a pediatric patient: pharmacokinetic and pharmacogenetic analysis

Published:2015-09-24 Issue:2 Volume:72 Page:247-248
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Marano M.,Bottaro G.,Goffredo B.,Stoppa F.,Pisani M.,Marinaro A. M.,Deodato F.,Dionisi-Vici C.,Clementi E.,Falvella F. S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-015-1956-2.pdf

Reference10 articles.

1. Aycicek A, Koc A, Abuhandan M (2010) Efficacy of deferasirox in children with β-thalassemia: single-center 3 year experience. Pediatr Int 56(4):530–3. doi: 10.1111/ped.12323 , Epub 2014 May 30

2. Cappellini MD, Bejaoui M, Agaoglu L, Canatan D et al (2011) Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years’ follow-up. Blood 118(4):884–93. doi: 10.1182/blood-2010-11-316646 , Epub 2011 May 31

3. Bruin GJ, Faller T, Wiegand H, Schweitzer A et al (2008) Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats. Drug Metab Dispos 36(12):2523–38. doi: 10.1124/dmd.108.022962 , Epub 2008 Sep 5

4. Stingl JC, Bartels H, Viviani R, Lehmann ML, Brockmöller J (2014) Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: a quantitative systematic review. Pharmacol Ther 141(1):92–116. doi: 10.1016/j.pharmthera.2013.09.002 , Epub 2013 Sep 27. Review

5. Han JY, Lim HS, Shin ES, Yoo YK et al (2006) Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol 24:2237–44, Epub 2006 Apr 24

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Manuka combinations with nigella sativa and hydroxyurea in treating iron overload of pediatric β-thalassemia major, randomized clinical trial;Heliyon;2024-07

2. 44th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 28–31 May 2024, Munich, Germany;Clinical Toxicology;2024-05

3. Evidence for the Metabolic Activation of Deferasirox In Vitro and In Vivo;Chemical Research in Toxicology;2023-07-12

4. Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease;British Journal of Haematology;2023-03-25

5. Genomic Insights of Bruneian Malays;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3